Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder

Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder - Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005257

Enrollment

Registered

2011-04-01

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

long-chain fatty acid beta-oxydation disorder

Interventions

bezafibrate for internal use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with long-chain fatty acid beta-oxydation disorder

Exclusion criteria

Exclusion criteria: a case who dosen't approve this clinical trial

Design outcomes

Primary

Measure	Time frame
improvement of clinical symptoms (muscle pain etc.)	—

Countries

Japan

Contacts

Public ContactHiroyuki Awano

Kobe University Graduate School of Medicine Pediatrics

awahiro@med.kobe-u.ac.jp078-382-6090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026